EPO Patents = 5

Forward Citations = 0

Loading Chart...

9 inventors (with patents filed for the assignee):

Leena Hirvelä (7 out of 7 patents)

Pasi Koskimies (7 out of 15 patents)

Risto A Lammintausta (5 out of 23 patents)

4. Marjo Hakola (4 out of 5 patents)

5. Maire Eloranta (4 out of 9 patents)

6. Mikko Unkila (3 out of 8 patents)

7. Lauri V Kangas (3 out of 35 patents)

8. Camilla Stjernschantz (2 out of 3 patents)

9. Tero Linnanen (2 out of 7 patents)

10. Leena HirvelÄ (1 patent)

7 patents: Sort by Forward Citations

1. 11254703 - Therapeutically active steroidal derivatives (2022-02-22),

2. 10717761 - Therapeutically active steroidal derivatives (2020-07-21),

3. 10626140 - Prodrugs of 17β-HSD1-inhibitors (2020-04-21),

4. 10413557 - Prodrugs of 17.BETA.-HSD1-inhibitors (2019-09-17),

5. 10377791 - Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1 (2019-08-13),

6. 9850272 - Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1 (2017-12-26),

7. 9663549 - Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase (2017-05-30),

Forendo Pharma is a clinical stage drug development company focusing on a novel treatment approach for endometriosis, a chronic gynecological condition affecting millions of women worldwide. The company is dedicated to developing innovative therapies to address significant unmet medical needs in the field of women's health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

7 Patents

#14 in Turku

#403 in Finland

Turku, Finland

Forendo Pharma Ltd